Search research articles
Contact Us
Filters
Showing results (91-100 of 1,381) with videos related to
Page
of 139
Sort By:
Journal of Pharmaceutical Sciences
|
May 1, 1979
High-performance liquid chromatographic assay for the antiprotozoal agent, tinidazole, in human plasma
K B Alton, J E Patrick
Current Pharmaceutical Design
|
January 11, 2012
Progress in gene and cell therapy for cystic fibrosis lung disease
Uta Griesenbach, Eric W F W Alton
Expert Review of Respiratory Medicine
|
May 19, 2010
Cystic fibrosis gene therapy: successes, failures and hopes for the future
Uta Griesenbach, Eric W F W Alton
Transfusion
|
February 16, 2021
Factors driving availability of COVID-19 convalescent plasma: Insights from a demand, production, and supply model
W Alton Russell, Eduard Grebe, Brian Custer
Radiology
|
June 1, 1992
Pneumatic reduction of intussusception: 5-year experience
M Stein, D J Alton, A Daneman
Pediatric Radiology
|
January 1, 1988
Transient opacification of the urinary pathways by amorphous debris in children with leukemia
D J Alton, L Gu, A Daneman
F1000Prime Reports
|
June 23, 2015
Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction
Uta Griesenbach, Eric W F W Alton
Current Opinion in Pulmonary Medicine
|
September 2, 2016
Cystic fibrosis gene therapy: a mutation-independent treatment
Uta Griesenbach, Jane C Davies, Eric Alton
Human Molecular Genetics
|
August 7, 2013
Moving forward: cystic fibrosis gene therapy
Uta Griesenbach, Eric W F W Alton
The American Journal of Clinical Nutrition
|
January 1, 1978
The physical and neuromotor development of progeny of female rats fed graded levels of pyridoxine during lactation
M G Alton-Mackey, B L Walker
Page
of 139
Search research articles
Search
Showing results (91-100 of 1,381) with videos related to
Sort By:
Page
of 139
Journal of Pharmaceutical Sciences
|
May 1, 1979
High-performance liquid chromatographic assay for the antiprotozoal agent, tinidazole, in human plasma
K B Alton, J E Patrick
Current Pharmaceutical Design
|
January 11, 2012
Progress in gene and cell therapy for cystic fibrosis lung disease
Uta Griesenbach, Eric W F W Alton
Expert Review of Respiratory Medicine
|
May 19, 2010
Cystic fibrosis gene therapy: successes, failures and hopes for the future
Uta Griesenbach, Eric W F W Alton
Transfusion
|
February 16, 2021
Factors driving availability of COVID-19 convalescent plasma: Insights from a demand, production, and supply model
W Alton Russell, Eduard Grebe, Brian Custer
Radiology
|
June 1, 1992
Pneumatic reduction of intussusception: 5-year experience
M Stein, D J Alton, A Daneman
Pediatric Radiology
|
January 1, 1988
Transient opacification of the urinary pathways by amorphous debris in children with leukemia
D J Alton, L Gu, A Daneman
F1000Prime Reports
|
June 23, 2015
Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction
Uta Griesenbach, Eric W F W Alton
Current Opinion in Pulmonary Medicine
|
September 2, 2016
Cystic fibrosis gene therapy: a mutation-independent treatment
Uta Griesenbach, Jane C Davies, Eric Alton
Human Molecular Genetics
|
August 7, 2013
Moving forward: cystic fibrosis gene therapy
Uta Griesenbach, Eric W F W Alton
The American Journal of Clinical Nutrition
|
January 1, 1978
The physical and neuromotor development of progeny of female rats fed graded levels of pyridoxine during lactation
M G Alton-Mackey, B L Walker
Page
of 139